← FDA Drug Approvals (Drugs@FDA)

BORTEZOMIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2022-07-26

Drug application

FDA Application #

ANDA204405

Application type

Abbreviated New Drug Application (Generic)

Brand name

BORTEZOMIB

Generic name

Bortezomib

Active ingredients

BORTEZOMIB

Dosage form

INJECTABLE

Route

INTRAVENOUS, SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

ACCORD HLTHCARE

First approval

2022-07-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown